
Canadian department store chain Hudson’s Bay is trying to acquire Kohl’s, a source familiar with the situation told Reuters for its report Wednesday (March 16).
Kohl’s shares neared $63 on Wednesday, which would value the company at $8.76 billion. The Wall Street Journal reported that private equity firm Sycamore Partners and Hudson’s Bay are planning to make bids in “the high $60s per share” for Kohl’s, which has asked for bids by Wednesday.
Kohl’s believes it’s worth more than $70 per share, according to one of the sources.
Sycamore Partners declined to comment on the situation. Axios had the first report about Hudson’s Bay considering making a bid for Kohl’s, which rejected two buyout offers valuing it at between $64 and $65 per share from Sycamore and Starboard Value-backed Acacia Research.
Kohl’s officials said this month that investment bank Goldman Sachs spent January, February and March talking to more than 20 parties about its next steps, adding it had provided a few of them access to more financial data.
“The board will measure potential bids against a compelling standalone plan,” Kohl’s said in an emailed response to Reuters on Wednesday, adding that the process was “robust and ongoing.”
In December, activist investors urged Kohl’s, the second-largest U.S. department store chain, to either sell itself outright or consider a spin-off of its eCommerce division in a bid to boost its stock price.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas